EN PL

FDA: Electronic Source Data in Clinical Investigations

20.09.2013
This guidance provides recommendations to sponsors, Contract Research Organizations (CROs), clinical investigators, and others involved in the capture, review, and retention of electronic source data in FDA-regulated clinical investigations.